Skip to main content
KBS_Icon_questionmark link-ico


Rebecca joined the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) in 2017 as a visiting researcher working on the SINaPs study investigating the role of NMDAR antibodies in psychosis. In 2018, Rebecca began working on the STRATA study at the IoPPN as a research assistant, investigating treatment response in schizophrenia.

Since 2019, Rebecca has been working on the eBRAIN study with Professor Paola Dazzan, investigating the impact of childhood adversity on adolescent neurodevelopment and psychopathology. She began studying for her PhD (part-time) in October 2020, looking at neuroimaging correlates of adolescent resilience using fMRI data from the eBRAIN study.

Research interests

  • Early life stress
  • Adolescent neurodevelopment
  • Resilience
  • Neuroimaging
  • Immuno-psychiatry

Key publications

  • Lennox, B., Yeeles, K., Jones, P. B., Zandi, M., Joyce, E., Yu, L. M., Cairns, I. (2019). Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2). Trials, 20(1), 331.
  • Lennox, B. R., Tomei, G., Vincent, S. A., Yeeles, K., Pollard, R., Palmer-Cooper, E., Coles, A. (2019). Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1). J Neurol Neurosurg Psychiatry, 90(3), 365-367.